Johnson & Johnson

FDA, companies to study metal-on-metal implant effects

  • Mon, 07/02/2012 - 4:06pm

The FDA recently asked a panel of experts to recommend guidelines for monitoring over 500,000 patients with metal-on-metal hip replacements.

Johnson & Johnson ignored FDA demand

  • Wed, 06/27/2012 - 10:11am

Johnson & Johnson sold its Gynecare Prolift vaginal mesh implant for nine months after the Food and Drug Administration ordered the implant to be taken off the market, Bloomberg News reported y